PharmaMar

Jazz and PharmaMar Zepzelca for small cell lung cancer

Marketing

Jazz charts new path for Zepzelca after SCLC trial flop

If successful, the phase 3 trial could have served as the confirmatory trial to convert Zepzelca’s accelerated approval earned into a full one.

Angus Liu Sep 9, 2021 11:00am

Jazz and PharmaMar Zepzelca for small cell lung cancer

Jazz preps first solid tumor launch with Zepzelca

Jun 22, 2020 10:51am